Navigation Links
A Vaccine against Cancer

UK scientists have developed a revolutionary vaccine for cancer that triggers the body’s immune system to destroy and shrink tumors.// The vaccine is expected to be available within three years.

The vaccine has shown remarkable results in clinical trials, leading to hopes that this could be the answer for the tens of thousands of people that are afflicted by cancer each year.

In one patient who had been given the vaccine the tumor was seen to have disappeared for over six months. Two other patients have seen shrinking of their tumors while in three others the cancer has been halted in its tracks.

The researchers said results were “exciting” and “very encouraging”.

Oxford BioMedica is the British company that is behind this vaccine which is initially hoped to serve as a treatment for kidney and bowel cancer. Subsequently this vaccine could be beneficial in the treatment of other forms of cancer as well.

It is said that to date 150 patients have been administered the vaccine and 95 per cent of those that can be evaluated have had an “anti-tumour response”. If further trials prove successful, the vaccine could be licensed for use against kidney cancer within three years.

Experts have claimed that the data appears to indicate that “gene therapy” vaccine could prove an effective treatment for a whole range of cancers. The new vaccine, TroVax works in a way totally different from existing treatments by harnessing the patient's own immune system to fight the disease.

Data from a trial involving 34 people with kidney cancer that is renal cell carcinoma was revealed at a medical conference in Prague from the Phase II trial, in which these people had the vaccine on its own or in combination with other standard treatments.

According to doctors renal cell carcinoma is a particularly aggressive form of kidney cancer accounting for over 80 per cent of the 6,000 cases of kidney cancer diagnosed each year i n the UK and causing a death toll of 3,400 lives annually.

One patient among the 18 patients given the treatment along with a drug called interleukin-2 saw his tumor totally disappear. Two other patients have seen shrinking of their tumors. In three other patients the disease has been stable for more than three months with one patient finding his disease has halted for more than 46 weeks.

However the vaccine appeared to work only for the “clear cell renal cell carcinoma” type of kidney cancer. However for those suffering from “papillary renal cell carcinoma” no response was seen to the treatment during the trials.



Source-Medndia
NLA
'"/>




Related medicine news :

1. Vaccine to quit smoking?
2. First Vaccine Designed for Africa Cleared for Testing in Humans
3. Vaccine for Alzheimer’s diseas
4. Health Officials Recommend Flu Vaccine
5. Smallpox Vaccine May Help Fight Cervical Cancer
6. Panacea Biotech To Market Anthrax Vaccine
7. New Prostate Cancer Vaccine Shows Promise
8. Drug Firm Offers to Donate Smallpox Vaccine
9. Vaccine guards against shingles
10. Vaccine for septic conditions
11. A new Vaccine for Pneumonia
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... October 13, 2017 , ... PurhealthRX , a leading Health ... technology. Applying the Purzorb™process to full spectrum CBD oil will revolutionize the rapidly growing ... form that can be easily incorporated into liquid products, while reducing costs to end ...
(Date:10/13/2017)... ... October 13, 2017 , ... Apple Rehab Shelton ... staged a mock evacuation of the facility as part of a disaster drill on ... Echo Hose EMS and Shelton City Emergency Manager, as well as the Connecticut ...
(Date:10/13/2017)... ... 13, 2017 , ... Ellevate Network, the leading network for professional women, brought ... gender equality at their inaugural Summit in New York City in June. The event ... audience of over 3 million. To watch the Mobilize Women video, click here ...
(Date:10/13/2017)... ... ... Talented host, actor Rob Lowe, is introducing a segment ... of "Success Files," which is an award-winning educational program broadcasted on PBS Member ... with passion and integrity. , Sciatica occurs when the sciatic nerve in the ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... “America On ... Christian identity. “America On The Brink” is the creation of published author, William ... several great-grandchildren. As a WWII veteran, he spent thirty years in the Navy. ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... -- Hill-Rom Holdings, Inc. (NYSE: HRC), will host its ... on Friday, November 3, 2017, beginning at 7:00 a.m. ... 8:30 a.m. (CDT) / 9:30 a.m. (EDT). ... and guidance for 2018, Hill-Rom executives will also highlight ... and long-range financial outlook through 2020. ...
(Date:9/25/2017)... R.I. , Sept. 25, 2017  EpiVax, ... assessment, vaccine design, and immune-engineering today announced the ... on the development of personalized therapeutic cancer vaccines. ... has provided exclusive access to enabling technologies to ... Eng., MBA will lead EpiVax Oncology as Chief ...
(Date:9/19/2017)... ZirMed Inc ., a recognized leader in cloud-based revenue cycle ... ranked #1 by its users for the seventh consecutive year ... ZirMed was recognized as the top-ranked end-to-end revenue cycle management ... 200 beds and holds one of the longest #1 ranking ... ...
Breaking Medicine Technology: